SMITH & NEPHEW PLC
14 August 2024
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020
On 13 August 2024, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.
All figures in these columns are stated to 6 decimal places where applicable.
i. PARTIAL VESTING OF 2021 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
The awards were granted under the Global Share Plan 2020 on 13 August 2021 and vest in three equal tranches in the following three years, with the award vesting on 13 August 2024 being the final tranche. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to individuals included in the below notification:
| Reason for the notification | |
| Initial notification /Amendment | Initial notification |
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| Name | Smith & Nephew plc |
| LEI | 213800ZTMDN8S67S1H61 |
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
| Identification code | ISIN: GB0009223206 |
| Nature of the transaction | Partial vesting on 13 August 2024 of Conditional Share awards granted on 13 August 2021 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability |
| Date of Transaction | 2024 - 08 - 13 |
| Place of Transaction | London Stock Exchange (XLON) |
| Name (Position) | Status | Price (£) | Volume | Aggregated information |
| Craig Gaffin (President Orthopaedics) | PDMR | 11.403054 | 595 (of which 146 were sold and 449 were retained.) | N/A Single Transaction |
| Alison Parkes (Chief Compliance Officer) | PDMR | 11.403054 | 1,218 (of which 447 were sold and 771 were retained.) | N/A Single Transaction |
ii. PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to individuals included in the below notification:
| Reason for the notification | |
| Initial notification /Amendment | Initial notification |
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| Name | Smith & Nephew plc |
| LEI | 213800ZTMDN8S67S1H61 |
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
| Identification code | ISIN: GB0009223206 |
| Nature of the transaction | Partial vesting on 11 August 2023 of Conditional Share awards granted on 11 August 2024 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability |
| Date of Transaction | 2024 - 08 - 13 |
| Place of Transaction | London Stock Exchange (XLON) |
| Name (Position) |
Status | Price (£) | Volume | Aggregated information |
| Rohit Kashyap (President, Advanced Wound Management and Global Commercial Operations) | PDMR | 11.403054 | 23,201 (of which 5,670 were sold and 17,531 were retained.) | N/A Single Transaction |
Helen Barraclough
Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.